Mike Matson
Stock Analyst at Needham
(3.35)
# 1,023
Out of 5,139 analysts
540
Total ratings
46.06%
Success rate
4.05%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Downgrades: Hold | n/a | $350.78 | - | 14 | Jan 16, 2026 | |
| NEO NeoGenomics | Reiterates: Buy | $14 | $12.79 | +9.46% | 28 | Jan 12, 2026 | |
| ESTA Establishment Labs Holdings | Reiterates: Buy | $84 | $67.51 | +24.43% | 6 | Jan 12, 2026 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $82.31 | +31.21% | 32 | Jan 9, 2026 | |
| HAE Haemonetics | Downgrades: Hold | n/a | $72.17 | - | 16 | Dec 15, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $148 → $166 | $143.37 | +15.78% | 14 | Dec 8, 2025 | |
| SYK Stryker | Reiterates: Buy | $448 | $363.78 | +23.15% | 10 | Nov 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.21 | +147.93% | 22 | Nov 13, 2025 | |
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $4.25 → $9 | $6.64 | +35.64% | 2 | Nov 11, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $58 | $43.39 | +33.67% | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $9.89 | +1.11% | 21 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $41.57 | +5.85% | 18 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $26 | $18.35 | +41.69% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.98 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $121 | $88.07 | +37.39% | 34 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.94 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $62.11 | +3.04% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $96.76 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $23.97 | +104.42% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $39.06 | +15.21% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $41.57 | +46.74% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.25 | +92.00% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $142.06 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $156.17 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $268.65 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $103.00 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $87.31 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $257.58 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $17.00 | +147.06% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $93.47 | -19.76% | 1 | Feb 18, 2021 |
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $350.78
Upside: -
NeoGenomics
Jan 12, 2026
Reiterates: Buy
Price Target: $14
Current: $12.79
Upside: +9.46%
Establishment Labs Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $84
Current: $67.51
Upside: +24.43%
Merit Medical Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $108
Current: $82.31
Upside: +31.21%
Haemonetics
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $72.17
Upside: -
TransMedics Group
Dec 8, 2025
Maintains: Buy
Price Target: $148 → $166
Current: $143.37
Upside: +15.78%
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $448
Current: $363.78
Upside: +23.15%
Lucid Diagnostics
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.21
Upside: +147.93%
Insight Molecular Diagnostics
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $6.64
Upside: +35.64%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $58
Current: $43.39
Upside: +33.67%
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $9.89
Upside: +1.11%
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $41.57
Upside: +5.85%
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $18.35
Upside: +41.69%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.98
Upside: -
Oct 17, 2025
Reiterates: Buy
Price Target: $121
Current: $88.07
Upside: +37.39%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.94
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $62.11
Upside: +3.04%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $96.76
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $23.97
Upside: +104.42%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $39.06
Upside: +15.21%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $41.57
Upside: +46.74%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.25
Upside: +92.00%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $142.06
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $156.17
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $268.65
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $103.00
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $87.31
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $257.58
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $17.00
Upside: +147.06%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $93.47
Upside: -19.76%